By Redaction ARPS Media with University of Cambridge
Researchers from Cambridge want public health organizations, such as the NHS, to offer trustworthy, research-based options instead of profit-driven menstrual tracking apps that generate revenue by selling user data.
A report from the Minderoo Centre points out the privacy risks faced by women, such as job discrimination, health insurance bias, and cyberstalking, which arise from the commercialization of their menstrual cycle data.
The report recommends stronger regulations for the femtech industry and suggests that public health apps prioritize user consent and privacy.
With the market for menstrual tracking expected to surpass $60 billion by 2027, the researchers emphasize the need for a clear NHS app to protect users and support medical research. They emphasize that menstrual tracking data should not be viewed solely as consumer data.
Read original article at: Menstrual tracking app data is a ‘gold mine’ for advertisers that risks women’s safety – report | University of Cambridge
